Pancreatic Cancer Research

ResearcherShenzhen UniversityActive in the last 2 years

Jiahui Yuan

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer. Co-author DOI 10.1186/s12885-025-14096-x↗
  2. SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. Co-author DOI 10.1016/j.canlet.2024.216733↗
  3. Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. Co-author DOI 10.1016/j.drup.2023.101005↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xianbin Zhang · 3 shared papers, 2023–2025 · strength 0.66
  2. Pingping Zhang · 2 shared papers, 2024–2025 · strength 0.51
  3. Milad Ashrafizadeh · 2 shared papers, 2023–2024 · strength 0.36
  4. Yongcheng Su · 1 shared paper, 2025 · strength 0.30
  5. Peng Gong · 1 shared paper, 2025 · strength 0.30
  6. Peng Gong · 1 shared paper, 2024 · strength 0.21
  7. Weiguang Li · 1 shared paper, 2023 · strength 0.15
  8. Peng Gong · 1 shared paper, 2023 · strength 0.15
  9. Wei Zhang · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.